CUSIP 87164U508COM NEWTOVXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
21 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 255.7K | $53.7K | +239.3K | Added |
| 2 | Geode Capital Management, LLC | 212.1K | $44.6K | +183.9K | Added |
| 3 | Morgan Stanley | 200.0K | $42.1K | +200.0K | New |
| 4 | Ubs Group AG | 191.4K | $40.2K |
| Added |
| 5 | Ikarian Capital, LLC | 112.1K | $23.6K | −8.0K | Reduced |
| 6 | Two Sigma Securities, LLC | 42.9K | $9.0K | +42.9K | New |
| 7 | Two Sigma Investments, LP | 42.3K | $8.9K | −19.5K | Reduced |
| 8 | Drw Securities, LLC | 41.7K | $8.8K | +41.7K | New |
| 9 | Xtx Topco Ltd | 39.4K | $8.3K | +6.5K | Added |
| 10 | Stonex Group Inc. | 37.2K | $7.8K | +37.2K | New |
See every fund holding Theriva Biologics Inc, with full quarter-over-quarter share changes.
Unlock all holders